MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
批准号:
3252439
负责人:
KATHLEEN E. RODGERS
金额:
$18.76万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1997-06-30
关键词:
arachidonate autoradiography basophils biomarker cellular immunity drug administration routes environmental toxicology gas chromatography guinea pigs histamine humoral immunity immunotoxicity insecticide biological effect laboratory mouse laboratory rat leukocyte oxidative burst macrophage mast cell pesticide interaction platelet activating factor thin layer chromatography tissue /cell culture tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The species and tissue specificity and the molecular mechanism of immune
modulation by the organophosphate pesticide, malathion, will be examined.
Acute oral administration of malathion to mice at low, noncholinergic
doses was shown to lead to peritoneal and dermal mast cell degranulation
and increased peritoneal leukocyte function. Based upon this, three
lines of inquiry will be pursued in this grant proposal. First, studies
are proposed to examine the effect of acute exposure to malathion on the
degranulation of basophilic cells from other tissues and from different
species. The effect of the route of administration on the degranulation
of mast cells will also be characterized. In addition, blood histamine
levels will be measured to possibly establish a biomarker for studies
involving occupational exposure. Second, examination of the contribution
of mast cell degranulation to the enhancement of immune and leukocyte
function that is observed after malathion administration is proposed.
Administration of malathion to mast cell-deficient mice with and without
reconstitution of the mast cell component and assessment of immune and
leukocyte function will be conducted. The mast cell mediators involved
in the increase in macrophage and immune function will be assessed
through the administration of inhibitors of mediator synthesis or
activity. The mast cell products that will be examined include
histamine, platelet-activating factor, arachidonic acid metabolites,
tumor necrosis factor and serotonin. In addition, studies to determine
the binding characteristics of malathion to mast cells and the effect of
metabolism on the activity and binding of malathion will also be
conducted. Lastly, the effects of subacute and subchronic administration
of malathion and acute administration of other organophosphate
pesticides, such as parathion and dichlorovos, on mast cell degranulation
and leukocyte function will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10530821
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10396541
-
项目类别:
-
资助金额:$151.56万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10644987
-
项目类别:
-
资助金额:$152.86万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:8058309
-
项目类别:
-
资助金额:$43.16万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:8055215
-
项目类别:
-
资助金额:$67.43万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7609180
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7797462
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:7552457
-
项目类别:
-
资助金额:$90.74万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7462238
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:7575590
-
项目类别:
-
资助金额:$94.23万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7414073
-
项目类别:
-
资助金额:$85.92万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:8134084
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7270998
-
项目类别:
-
资助金额:$92.41万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7624290
-
项目类别:
-
资助金额:$86.08万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10172751
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10412244
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10659128
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6945913
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6741664
-
项目类别:
-
资助金额:$96.03万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
ANGIOTENSIN ANALOGS TO TREAT WOUND HEALING
-
批准号:6292904
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
海外基金